All Notes

Non-melanoma skin cancer (NMSC): An Overview of Introduction, Types, Pathogenesis,Lab Diagnosis, Treatment, Prevention, and Keynotes

Introduction and Types

Non-melanoma skin cancer (NMSC) represents a group of cancers that develop in the upper layers of the skin, distinct from melanoma. They are the most commonly diagnosed malignancies worldwide. While they grow slowly and rarely metastasize compared to melanoma, they can cause significant local tissue destruction if left untreated.

NMSC primarily arises from keratinocytes in the epidermis.

  • Basal Cell Carcinoma (BCC): The most common type (~70-80%), originating in the deepest part of the epidermis. It is slow-growing and rarely spreads.
  • Squamous Cell Carcinoma (SCC): The second most common type (~20-25%), arising from thin, flat squamous cells in the outer epidermis. It has a slightly higher risk of metastasis than BCC.
  • Rare Types: Include Merkel cell carcinoma (aggressive neuroendocrine tumor), Kaposi sarcoma, Cutaneous T-cell lymphoma, and Sebaceous carcinoma.

Pathogenesis

The development of NMSC is a complex process driven by genetic and environmental factors.

  • UV Radiation: The primary driver, causing DNA damage (specifically p53 mutations) and immunosuppression.
  • Molecular Pathways:
    • BCC: Frequently linked to abnormal Hedgehog (HH) signaling, often involving PTCH1 mutations.
    • SCC: Characterized by a high mutational burden and often preceded by Actinic Keratosis (AK), a precancerous lesion.
  • Other Factors: X-rays, HPV infection, arsenic exposure, and chronic inflammation.

Lab Diagnosis

Diagnosis relies on visual inspection followed by definitive laboratory testing.

  • Physical Exam & Dermoscopy: Doctors use magnifying devices to inspect suspicious growths or non-healing sores.
  • Skin Biopsy (Gold Standard): A tissue sample is removed and analyzed histopathologically. Types include:
    • Excision Biopsy: Removing the entire lesion.
    • Punch or Shave Biopsy: Removing a small piece for testing.
  • Imaging & Blood Tests: CT scans or blood tests are typically only used if metastasis (spread) is suspected.

Treatment

Treatment is highly effective, especially when the cancer is caught early.

  • Surgical Options:
    • Mohs Micrographic Surgery: The gold standard for high-risk areas like the face; it removes layers of skin until only cancer-free tissue remains.
    • Simple Excision: Cutting out the cancer and a margin of healthy skin.
    • Curettage and Electrodessication: Scraping and “burning” the cancer.
  • Non-Surgical Options:
    • Cryosurgery: Freezing cancer cells with liquid nitrogen.
    • Radiation Therapy: Used when surgery isn’t optimal.
    • Topical Therapies: Creams like Imiquimod or 5-fluorouracil for superficial cases.
    • Systemic Therapy: Hedgehog inhibitors (e.g., Vismodegib) or Immunotherapy (e.g., Cemiplimab) for advanced or metastatic disease.

Prevention and Keynotes

  • Prevention: The most effective defense is daily use of SPF 30+ sunscreen, wearing protective clothing, and avoiding sun exposure between 10 AM and 4 PM.
  • Keynotes:
    • Risk Factors: Pale skin, age (over 50), and a history of previous skin cancer.
    • Warning Signs: Look for new growths, changes in existing moles, or sores that do not heal within 2–4 weeks.
    • Regular Exams: Monthly self-exams and annual dermatologist check-ups are vital for early detection.

Further Readings

  1. https://my.clevelandclinic.org/health/diseases/nonmelanoma-skin-cancer
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC5874663/
  3. https://www.mdpi.com/2227-9059/6/1/6
  4. https://www.mdpi.com/2227-9059/6/1/6
  5. https://www.mdpi.com/2227-9059/12/7/1448
  6. https://www.mayoclinic.org/diseases-conditions/nonmelanoma-skin-cancer/diagnosis-treatment/drc-20579827
  7. https://www.nhs.uk/conditions/non-melanoma-skin-cancer/tests-and-next-steps/
  8. https://www.cancerresearchuk.org/about-cancer/skin-cancer/getting-diagnosed/tests
  9. https://www.cancervic.org.au/about-cancer/types/skin_cancers_non_melanoma/diagnosing_skin_cancer.html
  10. https://www.todaysgeriatricmedicine.com/archive/ND17p30.shtml
  11. https://www.skincancercareqld.com.au/skin-cancer/non-melanoma-skin-cancer/
  12. https://www.uclahealth.org/news/article/how-prevent-skin-cancer
  13. https://www.mayoclinic.org/diseases-conditions/nonmelanoma-skin-cancer/symptoms-causes/syc-20355397
Medical Lab Notes

Recent Posts

Rapid Diagnostic Test for Visceral Leishmaniasis (Kala-azar): Introduction, Principle, Procedure, Result-Interpretation, Clinical Significance and Keynnotes

Introduction The Rapid Diagnostic Test (RDT) for Visceral Leishmaniasis (VL), often known as the rK39…

46 minutes ago

HLA -B27 Test: Introduction, Principle, Procedure, Result-Interpretation, Clinical Significance, and Keynotes

Introduction HLA-B27 (Human Leukocyte Antigen B27) is a specific genetic variant of the HLA-B gene…

7 hours ago

Infection Prevention & Control and Waste Management: Introduction, Procedure, Waste segregation, Disposal, Application, and Keynotes

Introduction Infection Prevention and Control (IPC) and Healthcare Waste Management (HCWM) are critical systems used…

18 hours ago

Orientia and Rickettsia: Introduction, Comparison, Key Differences, Treatment and Diagnosis

Introduction Orientia and Rickettsia are two closely related genera of bacteria within the family Rickettsiaceae.…

1 day ago

Biosafety Officer: Introduction, Roles, Uses, Clinical Significance, and Keynotes

Introduction A Biosafety Officer (BSO) is a technical expert responsible for the strategic and integrated…

1 day ago

Immunohistochemistry (IHC): Introduction, Application, and Keynotes

Introduction to IHC Immunohistochemistry (IHC) is a powerful laboratory technique that combines anatomical, immunological, and…

2 days ago